HomeStock ScreenerNatural Biocon

Natural Biocon Share Price | Natural Biocon Stock Screener

NATURAL Pesticides & Agrochemicals
Share Price BSE
₹3.56
▲ 0.04 (1.14%)
2026-07-20 00:00:00
As of July 20, 2026, the Natural Biocon share price (BSE: NATURAL) is ₹3.56, up 1.14% from the previous close, with shares trading between ₹3.26 and ₹3.75, and a 52-week range of ₹3.25–₹13.21. Analyse NATURAL price trends and track historical price performance. Use the Natural Biocon stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Natural Biocon Market Cap ₹9.25 Cr.
NATURAL P/E Ratio (TTM) -177.00
Natural Biocon P/B Ratio 0.30
EPS (TTM) ₹-0.02
Dividend Yield -
Debt to Equity 0.01
NATURAL 52 Week High ₹13.21
Natural Biocon 52 Week Low ₹3.25
Operating Margin -1.00%
Profit Margin -
NATURAL Revenue (TTM) ₹3.00
EBITDA -
Net Income -
Total Assets ₹37.00
Total Equity ₹31.00

Natural Biocon Share Price Chart

Screen Natural Biocon share price with an interactive chart. Analyse NATURAL price trends and volatility across different timeframes.

Natural Biocon Company Profile - Fundamental Screener

Screen Natural Biocon company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for NATURAL shares.
Sector Chemicals
Industry Pesticides & Agrochemicals
Sub-Sector Pesticides & Agrochemicals
Segment E
ISIN INE06MM01016

Natural Biocon Balance Sheet Screener

Screen NATURAL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017
Assets
Total Assets 37 39 17 14 12 12 13 13 13 12
Current Assets 5 7 6 2 1 2 2 2 2 1
Fixed Assets 3 0 0 0 0 0 0 0 0 0
Liabilities
Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 0 0 0 0 0 0 0 0 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 31 32 12 12 12 12 12 12 12 11
Share Capital 26 26 11 11 11 11 11 11 11 11
Reserves & Surplus 5 6 1 1 1 1 1 1 1 0

Natural Biocon Income Statement Screener - Profit & Revenue Analysis

Screen Natural Biocon income statement and profit fundamentals. Analyze NATURAL quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Natural Biocon share price evaluation.
Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March
Revenue 3 8 14 1 1 0 0 1 1 0 0 0
Expenses 3 8 13 1 0 0 0 0 0 0 0 0
EBITDA 0 0 0 0 0 0 0 0 1 0 0 0
Operating Profit % -1.00% 1.00% 2.00% 20.00% 18.00% 3.00% 0.00% 25.00% 96.00% 71.00% -1.00% -4.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 0 0 0 0 0 0 0 1 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 0 0 0 0 0 0 0 0 1 0 0 0
EPS -0.02 0.02 0.13 0.16 0.01 0.00 -0.07 0.06 0.62 0.01 0.00 0.00

Natural Biocon Cash Flow Screener - Liquidity Fundamentals

Screen NATURAL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March
Operating Activities 1 0 0 0 0 0 -1 0 0 0
Investing Activities -21 0 0 0 0 0 0 0 0 0
Financing Activities 20 0 0 0 0 0 1 0 0 0
Net Cash Flow 0 0 0 0 0 0 0 0 0 0

Natural Biocon Shareholding Pattern Screener

See Natural Biocon shareholding pattern with promoter, FII, and DII holdings. Check Natural Biocon promoter holding and ownership changes for NATURAL on TickJournal.
Item 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jul
Promoter Holding 9.36% 9.36% 9.36% 9.36% 9.36% 9.36% 9.36% 9.36%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 49.60% 47.93% 50.74% 53.82% 33.35% 33.35% 33.14% 33.08%
Other Holding 41.04% 42.71% 39.90% 36.82% 57.29% 57.29% 57.50% 57.56%
Shareholder Count 11,027 10,166 9,541 8,737 9,097 9,097 8,503 7,831

Natural Biocon Share Dividend Screener - Share Yield Analysis

Check Natural Biocon dividend history with payout and yield data. View Natural Biocon dividend details including ex-dates and amounts for NATURAL stock.
No dividends declared by Natural Biocon.

Natural Biocon Stock Index Membership

See which indices include Natural Biocon stock. Check NATURAL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Natural Biocon is not part of any tracked indices.
Only major market indices are tracked in our system.

Natural Biocon Market Events Screener - Corporate Actions

Get Natural Biocon corporate actions including splits, bonuses, and buybacks. Check Natural Biocon stock events that may affect NATURAL share price.
Announcement Date Record Date Event Type Information Price Impact
2026-07-04 2026-07-04 Annual General Meeting NA 0.58%
2026-05-09 2026-05-09 Quarterly Result Announcement NA -7.50%
2026-02-13 2026-02-13 Quarterly Result Announcement NA 1.69%
2025-11-14 2025-11-14 Quarterly Result Announcement NA -4.91%
2025-09-30 2025-09-30 Annual General Meeting NA -0.16%
2025-08-13 2025-08-13 Quarterly Result Announcement NA -1.39%
2025-05-29 2025-05-29 Quarterly Result Announcement NA 11.55%
2025-05-23 2025-05-23 Quarterly Result Announcement NA 6.93%
2025-02-14 2025-02-14 Quarterly Result Announcement NA -2.61%
2024-11-29 2024-11-29 Extraordinary General Meeting NA 4.12%
2024-11-09 2024-11-09 Quarterly Result Announcement NA -1.27%
2024-09-30 2024-09-30 Annual General Meeting NA -3.42%
2024-05-23 2024-05-23 Extraordinary General Meeting NA 10.80%

Natural Biocon Competitors Screener - Peer Comparison

Screen NATURAL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
UPL 50,072 22.50 51,839 10.01% 1,914 45.98
PI Industries 38,494 29.52 6,714 -19.33% 1,361 34.72
Sumitomo Chemical 26,714 48.92 3,385 3.56% 543 67.69
Bayer Crop Science 18,323 26.75 5,593 7.89% 568 37.38
Sharda Cropchem 8,178 12.06 5,268 20.28% 716 48.84
NACL Industries 5,051 1218.25 1,587 27.74% 5 55.80
Dhanuka Agritech 4,610 15.67 2,071 15.49% 297 36.19
Rallis 4,489 31.33 2,631 6.54% 164 49.68
Bhagiradha Chemicals & Industries 3,680 210.86 536 19.15% 16 53.90
Bharat Rasayan 2,245 15.72 1,242 3.57% 150 45.49

Natural Biocon Company Announcements - News Screener

Screen NATURAL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
Board Meeting Outcome for Resignation Of Directors -
2026-07-18 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-18 Closure of Trading Window -
2026-06-06 Board Meeting Outcome for AGM -
2026-06-05 Board Meeting Outcome for Appointment Of Ms. Shruti Sharma (M. No.: A52723) As Company Secretary And Compliance Officer Of The Company W.E.F. 05Th June 2026. -
2026-05-30 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-05-28 Board Meeting Intimation for Details Related To AGM -
2026-05-28 Unable To Conduct Board Meeting On 18Th May 2026 -
2026-05-11 Board Meeting Intimation for AGM -
2026-05-09 Audited Financial Results For The Quarter And Year Ended March 2026 -
2026-05-09 Board Meeting Outcome for Audited Financial Results Along With Auditors Report For The Quarter And Year Ended March 2026 -
2026-04-30 Board Meeting Intimation for Audited Results And Audit Report -
2026-04-28 Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A -
2026-04-22 Board Meeting Intimation for Audited Financial Result For The Quarter And Financial Year Ended On 31St March 2026 Along With The Auditors Report. -
2026-04-06 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-03-23 Closure of Trading Window -
2026-03-20 Board Meeting Outcome for Independent Directors Meeting -
2026-03-11 Board Meeting Intimation for Independent Directors Meeting -
2026-02-13 Un-Audited Financial Results (UFR) For The Third Quarter And Nine Months Ended December 31 2025 Along With The Statutory Auditors Limited Review Report. -
2026-02-13 Board Meeting Outcome for Un-Audited Financial Results (UFR) For The Third Quarter And Nine Months Ended December 31 2025 Along With The Statutory Auditors Limited Review Report. -